Expansion of PB CX3CR1+CD8+ T Cells Early After Initiation of Chemo-immunotherapy Correlates with Response and Better Prognosis in Patients with NSCLC. The gene discussed is CX3CR1; the disease is non-small cell lung carcinoma.